fridays glp 1 | GLP-1 Telehealth Commitment issues? Totally fine (we
Description
Over 1.5 years, patients who took Zepbound lost ~21% of their body weight, and an incredible 83% of them lost more than 10% of their body weight
R., Yang, B
Retatrutides 8.7% average at the same timepoint represents a 45-60% improvement in efficacy
Orland said he suspected the benefits observed were likely related to the drug itself, rather than resulting from better controlled diabetes or obesity, which can have an effect on cancer occurrences and outcomes
It is an investigational triple agonist that targets GIP, GLP-1, and glucagon receptors
The most precise estimates were for semaglutide, where the confidence intervals were narrower
